UA92641U - Method for correcting endothelial dysfunction in patients with unstable angina with comorbid arterial hypertension - Google Patents
Method for correcting endothelial dysfunction in patients with unstable angina with comorbid arterial hypertensionInfo
- Publication number
- UA92641U UA92641U UAU201403253U UAU201403253U UA92641U UA 92641 U UA92641 U UA 92641U UA U201403253 U UAU201403253 U UA U201403253U UA U201403253 U UAU201403253 U UA U201403253U UA 92641 U UA92641 U UA 92641U
- Authority
- UA
- Ukraine
- Prior art keywords
- endothelial dysfunction
- comorbid
- patients
- unstable angina
- arterial hypertension
- Prior art date
Links
- 206010048554 Endothelial dysfunction Diseases 0.000 title abstract 3
- 230000008694 endothelial dysfunction Effects 0.000 title abstract 3
- 206010002388 Angina unstable Diseases 0.000 title abstract 2
- 208000007814 Unstable Angina Diseases 0.000 title abstract 2
- 208000037849 arterial hypertension Diseases 0.000 title abstract 2
- 201000004332 intermediate coronary syndrome Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 206010047141 Vasodilatation Diseases 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 210000003038 endothelium Anatomy 0.000 abstract 2
- 230000024883 vasodilation Effects 0.000 abstract 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 abstract 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 abstract 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
- 230000002930 anti-sclerotic effect Effects 0.000 abstract 1
- 210000001367 artery Anatomy 0.000 abstract 1
- 229960005370 atorvastatin Drugs 0.000 abstract 1
- VHYCDWMUTMEGQY-UHFFFAOYSA-N bisoprolol Chemical compound CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1 VHYCDWMUTMEGQY-UHFFFAOYSA-N 0.000 abstract 1
- 229960002781 bisoprolol Drugs 0.000 abstract 1
- 210000002302 brachial artery Anatomy 0.000 abstract 1
- 238000012669 compression test Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000000803 paradoxical effect Effects 0.000 abstract 1
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 abstract 1
- 229960002582 perindopril Drugs 0.000 abstract 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A method for correcting the endothelial dysfunction in the patients with unstable angina with comorbid arterial hypertension consists in Dopplerography of the brachial artery measuring the diameter of the artery and the conventional Celermajer-Sorensen compression test with diagnosis of endothelium-dependent vasodilatation. The degree of endothelium-dependent vasodilatation (EDVD) is defined as the initial (EDVD 5.0-9.9 %), moderate (EDVD 0-4.9 %), or severe (from 0 to the paradoxical decrease of the value). The correction of the endothelial dysfunction is provided by the use of Bisoprolol as beta-adrenoblocker at a daily dose of 5-10 mg, Perindopril as an inhibitor of angiotensin-converting enzyme at a daily dose of 5-10 mg, Atorvastatin as antisclerotic drug at a daily dose of 20 mg for 6 months.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201403253U UA92641U (en) | 2014-03-31 | 2014-03-31 | Method for correcting endothelial dysfunction in patients with unstable angina with comorbid arterial hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201403253U UA92641U (en) | 2014-03-31 | 2014-03-31 | Method for correcting endothelial dysfunction in patients with unstable angina with comorbid arterial hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA92641U true UA92641U (en) | 2014-08-26 |
Family
ID=52682036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201403253U UA92641U (en) | 2014-03-31 | 2014-03-31 | Method for correcting endothelial dysfunction in patients with unstable angina with comorbid arterial hypertension |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA92641U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2699508C1 (en) * | 2018-07-25 | 2019-09-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Method of treating patients with metabolic syndrome |
-
2014
- 2014-03-31 UA UAU201403253U patent/UA92641U/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2699508C1 (en) * | 2018-07-25 | 2019-09-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Method of treating patients with metabolic syndrome |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4523617A3 (en) | Bisymmetric comparison of sub-epidermal moisture values | |
| EA201201309A1 (en) | PHARMACEUTICAL ACTIVE DERIVATIVES OF DOUBLE SUBSTITUTED TRIAZINE | |
| ZA201700196B (en) | Methods for treating high cardiovascular risk patients with hypercholesterolemia | |
| EA201300084A1 (en) | METHOD OF STERILIZATION AT THE LESSER MEASURE OF A SINGLE OBJECT, STERILIZATION DEVICE AND ITS APPLICATION | |
| EP4327866A3 (en) | Mirikizumab in the treatment of ulcerative colitis | |
| PH12015502679A1 (en) | Methods of treatment and compositions with xanthine oxidase inhibitors | |
| WO2019046568A8 (en) | High concentration dosage forms of pridopidine | |
| EA202090945A1 (en) | ANTI-MSLN-ANTIBODY AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ONCOLOGICAL DISEASES, CONTAINING IT | |
| EA202091308A1 (en) | MODIFIED BRUCELLA VACCINE STRAIN FOR THE TREATMENT OF BRUCELLOSIS | |
| UA92641U (en) | Method for correcting endothelial dysfunction in patients with unstable angina with comorbid arterial hypertension | |
| MA45831B1 (en) | ANTI-BEDBUG MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF | |
| CU20150173A7 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES AN HMG-Coa REDUCTASA INHIBITOR THAT MINIMIZES THE INTERACTION OF ACETILSALYCLIC ACID WITH STATIN | |
| EA201991373A1 (en) | ROR GAMMA MODULATORS (RORγ) | |
| EA202090028A1 (en) | METHODS FOR REDUCING OR PREVENTING CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE II DIABETES | |
| PH12017500786B1 (en) | Pharmaceutical composition comprising a beta blocker and an angiotensin converting enzyme inhibitor | |
| UA92638U (en) | Method for preventing emergence of primary end points in patients with unstable angina with comorbid arterial hypertension | |
| EA202090165A1 (en) | A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASES ASSOCIATED WITH DIABETES, CONTAINING AMLODIPINE, LOSARTAN AND ROSUVASTATIN, AND PREPARATION | |
| TWD193418S (en) | Human body sensor | |
| UA100403U (en) | METHOD OF PREVENTION OF DIABETES MELLITUS AND ITS COMPLICATIONS | |
| MX2017015658A (en) | Multi-peptide composition. | |
| RU2009117219A (en) | METHOD FOR DETERMINING THE DEGREE OF PHYSICAL ACTIVITY OF PATIENTS | |
| EA201500155A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING IPIDACRIN, AND THEIR APPLICATION FOR THE TREATMENT OF POTENTIAL DISORDERS AND DISORDERS OF OTHER FORMS OF SEXUAL ACTIVITY | |
| UA53584U (en) | Method for assessing treatment efficacy of isosorbid dinitrate in patients with ischemic heart disease suffering from angina pectoris and arterial hypertension | |
| MX2021009663A (en) | Treatment of pitt-hopkins syndrome. | |
| PL418702A1 (en) | Enthezamide-containing pharmaceutical composition in the form of a tablet |